These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 2099038)
1. Pathophysiological role of thromboxane A2 and pharmacological approaches to its inhibition. Patscheke H; Hornberger W; Zehender H Z Kardiol; 1990; 79 Suppl 3():151-4. PubMed ID: 2099038 [TBL] [Abstract][Full Text] [Related]
2. Biosynthesis and pharmacological modulation of thromboxane in humans. Patrono C Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814 [TBL] [Abstract][Full Text] [Related]
3. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis. Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist. Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268 [TBL] [Abstract][Full Text] [Related]
5. Current concepts for a drug-induced inhibition of formation and action of thromboxane A2. Patscheke H Blut; 1990 May; 60(5):261-8. PubMed ID: 2190651 [TBL] [Abstract][Full Text] [Related]
6. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists. Hanasaki K; Arita H Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322 [TBL] [Abstract][Full Text] [Related]
7. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related]
11. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review. Fiddler GI; Lumley P Circulation; 1990 Jan; 81(1 Suppl):I69-78; discussion I79-80. PubMed ID: 2136820 [TBL] [Abstract][Full Text] [Related]
12. Increased number of thromboxane A2-prostaglandin H2 platelet receptors in active unstable angina and causative role of enhanced thrombin formation. Modesti PA; Colella A; Cecioni I; Costoli A; Biagini D; Migliorini A; Neri Serneri GG Am Heart J; 1995 May; 129(5):873-9. PubMed ID: 7732975 [TBL] [Abstract][Full Text] [Related]
13. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo. Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815 [TBL] [Abstract][Full Text] [Related]
14. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets. Mais DE; Kochel PJ; Saussy DL; Halushka PV Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736 [TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction. Parise LV; Venton DL; Le Breton GC J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669 [TBL] [Abstract][Full Text] [Related]
16. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis. Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320 [TBL] [Abstract][Full Text] [Related]
17. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant. Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555 [TBL] [Abstract][Full Text] [Related]
18. 12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Fonlupt P; Croset M; Lagarde M Thromb Res; 1991 Jul; 63(2):239-48. PubMed ID: 1837628 [TBL] [Abstract][Full Text] [Related]
19. The biological role of thromboxane A2 in the process of hemostasis and thrombosis; pharmacology and perspectives of therapeutical use of thromboxane synthetase inhibitors and receptor PGH2/TXA2 antagonists. Radomski M Acta Physiol Pol; 1985; 36(3):153-64. PubMed ID: 3915630 [TBL] [Abstract][Full Text] [Related]
20. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets. Mayeux PR; Morton HE; Gillard J; Lord A; Morinelli TA; Boehm A; Mais DE; Halushka PV Biochem Biophys Res Commun; 1988 Dec; 157(2):733-9. PubMed ID: 2974286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]